Rafael Holdings, Inc. Class B Common Stock

RFLNYSE • USD
ThemeBiotech - Drug Development›Rare Disease Therapeutics
2.19 USD
↗ 0.41 (22.75%)🟢LIVE (AS OF 02:33 PM EDT)
🟢Market: OPEN

Rafael Holdings, Inc. Class B Common Stock (RFL) is currently trading at $2.19. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics place RFL at a fair price relative to peers.

Technical & fundamental data as of Jun 10, 2026.

Open?$1.76
High?$2.21
Low?$1.66
Prev. Close?$1.78
Volume?408.9K
Avg. Volume?117.3K
VWAP?$2.05
Rel. Volume?3.49x
Bid / Ask
Bid?$2.11 × 100
Ask?$2.15 × 900
Spread?$0.04
Midpoint?$2.13
Valuation & Ratios
Market Cap?92.6M
Shares Out?51.2M
Float?30.6M
Float %?60.0%
P/E Ratio?N/A
P/B Ratio?1.17
EPS?-$0.64
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.
Themes
Biotech - Drug Development›Rare Disease Therapeutics
Employees
23
Market Cap
92.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.rafaelholdings.com
Listed
2018-03-06
Address
520 BROAD STREET
NEWARK, NJ 07120
Phone: 212-658-1450
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
1
Momentum?
40
Short Sent.?
54
Piotroski F-Score?3/9Weak
Altman Z-Score?-0.85Distress
Confidence?56%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.22%Low
Short Interest?66.7K
Days to Cover?1.8
Free Float30.6M
Avg Daily Volume37.3K
Settlement Date2026-05-29
Financial Health
Current Ratio?3.44Strong
Quick Ratio?3.41Strong
Cash Ratio?3.06Strong
Debt/Equity?0.01Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
94
1.17CHEAP▾
P/S?
Peers
100
S&P
3
79.61HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.6CHEAP▾
EV/Sales?
Peers
100
S&P
3
47.69HIGH▾
Returns & Efficiency
ROE?
S&P
3
-41.8%WEAK▾
ROA?
S&P
3
-33.3%WEAK▾
Cash Flow & Enterprise
FCF?$-27899000
Enterprise Value?$55.5M
Fundamentals ratios updated end of day
MarketsMoversWatchlist